| __timestamp | Teva Pharmaceutical Industries Limited | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 5078000000 | 1802274 |
| Thursday, January 1, 2015 | 4717000000 | 2512761 |
| Friday, January 1, 2016 | 5096000000 | 2894488 |
| Sunday, January 1, 2017 | 4986000000 | 8096274 |
| Monday, January 1, 2018 | 4214000000 | 7985229 |
| Tuesday, January 1, 2019 | 3806000000 | 8994597 |
| Wednesday, January 1, 2020 | 3671000000 | 29772000 |
| Friday, January 1, 2021 | 3528000000 | 33907000 |
| Saturday, January 1, 2022 | 3445000000 | 26579000 |
| Sunday, January 1, 2023 | 3498000000 | 49868547 |
| Monday, January 1, 2024 | 3702000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, understanding spending patterns is crucial for strategic planning. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Teva Pharmaceutical Industries Limited and Verona Pharma plc from 2014 to 2023.
Teva, a global leader, saw a significant reduction in SG&A expenses, dropping by approximately 32% over the decade. This decline reflects strategic cost-cutting measures amidst industry challenges. In contrast, Verona Pharma, a smaller player, experienced a staggering increase of over 2,600% in SG&A expenses, indicating aggressive expansion and investment in growth.
The data highlights the contrasting strategies of these companies: Teva's focus on efficiency versus Verona's growth-oriented approach. As the pharmaceutical landscape continues to shift, these spending patterns offer valuable insights into the strategic priorities of industry leaders and emerging contenders alike.
Eli Lilly and Company and Teva Pharmaceutical Industries Limited: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of GSK plc and Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited vs Alpine Immune Sciences, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs TG Therapeutics, Inc.
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Amneal Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Limited and Merus N.V.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Teva Pharmaceutical Industries Limited vs Veracyte, Inc. Trends and Insights
Teva Pharmaceutical Industries Limited or Agios Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Teva Pharmaceutical Industries Limited and Geron Corporation: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Viatris Inc. and Verona Pharma plc
Breaking Down SG&A Expenses: Blueprint Medicines Corporation vs Verona Pharma plc
SG&A Efficiency Analysis: Comparing Verona Pharma plc and Arrowhead Pharmaceuticals, Inc.